• 20 Nov 19

SkinBioTherapeutics inks commercial deal with FTSE 100 chemical firm Croda

SkinBioTherapeutics inks commercial deal with FTSE 100 chemical firm Croda

SkinBioTherapeutics Plc | SBTX | 19.5 0.25 0.0%

    • 125 views

 

SkinBioTherapeutics PLC's (LON:SBTX) CEO Stuart Ashman speaks to Proactive London's Andrew Scott after announcing they've inked a commercial agreement for its skincare product with FTSE 100 speciality chemical company Croda International Plc (LON:CRDA).

Ashman says it's a significant first deal for them and provides third-party validation of its technology.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

AxisBiotix-Ps™ by SkinBioTherapeutics Hits Amazon U

Companies: SkinBioTherapeutics Plc

SkinBioTherapeutics assessing options for a 'rapid trial' of its food supplement

Companies: SkinBioTherapeutics Plc

London's FTSE 100 heads lower into the weekend

Companies: SkinBioTherapeutics Plc

SkinBioTherapeutics Plc - Welcome Ceremony

Companies: SkinBioTherapeutics Plc

SkinBioTherapeutics set for launch of probiotic food supplement for skin condition psoriasis

Companies: SkinBioTherapeutics Plc

Investor Update: SkinBio signs commercial deal with chemical giant Croda

Companies: SkinBioTherapeutics Plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top